Related Experiment Videos
[Wegener's disease of urologic and neurologic onset]
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease.
Behavioural neurology·2014
Segregation distortion in Lolium: evidence for genetic effects.
TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2008
Inflammatory pseudotumor of lymph nodes.
Annales de medecine interne·2004
[Necrolytic migratory erythema revealing glucagonoma without diabetes].
Annales de medecine interne·2004
[Bilateral primary non-Hodgkin's lymphomas of the adrenals].
Annales de medecine interne·2004
[Acute "pseudo-angiocholitis" due to colonic adenocarcinoma in a man with primary sclerosis cholangitis and ulcerative colitis].
Annales de medecine interne·2004
[Slipped capital femoral epiphysis associated with hyperparathyroidism. A case report].
Annales de medecine interne·2004
[Chronic fever revealing an urachal cyst].
Annales de medecine interne·2004
Impulse Control Disorders Are Independent of Parkinson Disease Motor Subtypes.
medRxiv : the preprint server for health sciences·2026
Neuroinflammation-associated thalamocortical functional connectivity and cognition in older adults.
Journal of neuroinflammation·2026
Neuroglobin positively regulates YTHDF3 to restore mitophagy and suppress ferroptosis in sevoflurane-induced developmental neurotoxicity.
Chemico-biological interactions·2026
Repetitive nerve stimulation in juvenile myasthenia gravis: Diagnostic strategy and area decrement value.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Elevated primary motor cortex GABA in Parkinson's disease: 7T MR spectroscopy evidence.
Parkinsonism & related disorders·2026
Non-canonical modulation of mitochondrial ROS and dynamics by Netrin-3 drives inflammasome activation in cardiomyocytes.
International immunopharmacology·2026